According to my opinion, there is not any justified reason, to sell shares of KIWA Biotechs at this moment. To the contrary, I think, that company is on a pretty good way and performing well. Just have a look on their recent quarter report. They have advanced more than 23 million dollars to their suppliers, which will become revenues in the next months. Additionally there is all the technical progress they have made recently.
As you might noticed, somebody was collecting lot of shares in the last days, as he understands the future of this company. And this persons founds a seller, who might be frustrated by the performance of the company or who needs some cash for personal reasons.
I think there is not any reason to be worried.
Market Data 
Markets 
AI
